Urinary prothrombin fragment 1+2 in patients with venous thrombosis and myocardial infarction

By Es J.  

Journal of Thrombosis and Thrombolysis, Vol. 36, Iss. 1, 2013-07 ,pp. : 47-49

Springer Publishing Company

Access to resources Recommend Favorite

Prothrombin Fragment 1 + 2 Measures Treatment Effect in Patients with Antiphospholipid Syndrome - Prevalance, risk, and interaction

By Yamazaki M.   Asakura H.   Saito M.   Jokaji H.   Uotani C.   Kumabashiri I.   Morishita E.   Aoshima K.   Matsuda T.   Triplett D.A.  

Thrombosis Research, Vol. 91, Iss. 3, 1998-08 ,pp. : 121-128

Elsevier

Access to resources Recommend Favorite

Expression of Prothrombin Fragment 1+2 in Cancer Tissue as an Indicator of Local Activation of Blood Coagulation

By Wojtukiewicz M.Z.   Rucinska M.   Zimnoch L.   Jaromin J.   Piotrowski Z.   Rozanska-Kudelska M.   Kisiel W.   Kudryk B.J.  

Thrombosis Research, Vol. 97, Iss. 5, 2000-03 ,pp. : 335-342

Elsevier

Access to resources Recommend Favorite

Modified Antithrombin III Levels during Normal Pregnancy and Relationship with Prothrombin Fragment F1+2 and Thrombin-antithrombin Complexes

By Reber G.   Amiral J.   de Moerloose P.  

Thrombosis Research, Vol. 91, Iss. 1, 1998-07 ,pp. : 45-47

Elsevier

Access to resources Recommend Favorite

Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays

By Tsutsumi Akito   Hayashi Taichi   Chino Yusuke   Mamura Mizuko   Goto Daisuke   Matsumoto Isao   Ito Satoshi   Sumida Takayuki  

Modern Rheumatology, Vol. 16, Iss. 3, 2006-06 ,pp. : 158-164

Springer Publishing Company

Access to resources Recommend Favorite